12-2679461-C-T

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2

The NM_000719.7(CACNA1C):​c.5109C>T​(p.Phe1703Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000492 in 1,423,846 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000049 ( 0 hom. )

Consequence

CACNA1C
NM_000719.7 synonymous

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.0920

Publications

1 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
ITFG2-AS1 (HGNC:53128): (ITFG2 antisense RNA 1)
CACNA1C-AS1 (HGNC:40119): (CACNA1C antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.38).
BP6
Variant 12-2679461-C-T is Benign according to our data. Variant chr12-2679461-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 527028.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.092 with no splicing effect.
BS2
High AC in GnomAdExome4 at 7 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1CNM_000719.7 linkc.5109C>T p.Phe1703Phe synonymous_variant Exon 42 of 47 ENST00000399655.6 NP_000710.5
CACNA1CNM_001167623.2 linkc.5109C>T p.Phe1703Phe synonymous_variant Exon 42 of 47 ENST00000399603.6 NP_001161095.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1CENST00000399603.6 linkc.5109C>T p.Phe1703Phe synonymous_variant Exon 42 of 47 5 NM_001167623.2 ENSP00000382512.1
CACNA1CENST00000399655.6 linkc.5109C>T p.Phe1703Phe synonymous_variant Exon 42 of 47 1 NM_000719.7 ENSP00000382563.1
CACNA1CENST00000682544.1 linkc.5343C>T p.Phe1781Phe synonymous_variant Exon 44 of 50 ENSP00000507184.1
CACNA1CENST00000406454.8 linkc.5109C>T p.Phe1703Phe synonymous_variant Exon 42 of 48 5 ENSP00000385896.3
CACNA1CENST00000399634.6 linkc.5076C>T p.Phe1692Phe synonymous_variant Exon 41 of 47 5 ENSP00000382542.2
CACNA1CENST00000683824.1 linkc.5274C>T p.Phe1758Phe synonymous_variant Exon 43 of 48 ENSP00000507867.1
CACNA1CENST00000347598.9 linkc.5253C>T p.Phe1751Phe synonymous_variant Exon 44 of 49 1 ENSP00000266376.6
CACNA1CENST00000344100.7 linkc.5232C>T p.Phe1744Phe synonymous_variant Exon 42 of 47 1 ENSP00000341092.3
CACNA1CENST00000327702.12 linkc.5109C>T p.Phe1703Phe synonymous_variant Exon 42 of 48 1 ENSP00000329877.7
CACNA1CENST00000399617.6 linkc.5109C>T p.Phe1703Phe synonymous_variant Exon 42 of 48 5 ENSP00000382526.1
CACNA1CENST00000682462.1 linkc.5199C>T p.Phe1733Phe synonymous_variant Exon 42 of 47 ENSP00000507105.1
CACNA1CENST00000683781.1 linkc.5199C>T p.Phe1733Phe synonymous_variant Exon 42 of 47 ENSP00000507434.1
CACNA1CENST00000683840.1 linkc.5199C>T p.Phe1733Phe synonymous_variant Exon 42 of 47 ENSP00000507612.1
CACNA1CENST00000683956.1 linkc.5199C>T p.Phe1733Phe synonymous_variant Exon 42 of 47 ENSP00000506882.1
CACNA1CENST00000399638.5 linkc.5193C>T p.Phe1731Phe synonymous_variant Exon 43 of 48 1 ENSP00000382547.1
CACNA1CENST00000335762.10 linkc.5184C>T p.Phe1728Phe synonymous_variant Exon 43 of 48 5 ENSP00000336982.5
CACNA1CENST00000399606.5 linkc.5169C>T p.Phe1723Phe synonymous_variant Exon 43 of 48 1 ENSP00000382515.1
CACNA1CENST00000399621.5 linkc.5166C>T p.Phe1722Phe synonymous_variant Exon 42 of 47 1 ENSP00000382530.1
CACNA1CENST00000399637.5 linkc.5166C>T p.Phe1722Phe synonymous_variant Exon 42 of 47 1 ENSP00000382546.1
CACNA1CENST00000402845.7 linkc.5166C>T p.Phe1722Phe synonymous_variant Exon 42 of 47 1 ENSP00000385724.3
CACNA1CENST00000399629.5 linkc.5160C>T p.Phe1720Phe synonymous_variant Exon 42 of 47 1 ENSP00000382537.1
CACNA1CENST00000682336.1 linkc.5151C>T p.Phe1717Phe synonymous_variant Exon 42 of 47 ENSP00000507898.1
CACNA1CENST00000399591.5 linkc.5133C>T p.Phe1711Phe synonymous_variant Exon 41 of 46 1 ENSP00000382500.1
CACNA1CENST00000399595.5 linkc.5133C>T p.Phe1711Phe synonymous_variant Exon 41 of 46 1 ENSP00000382504.1
CACNA1CENST00000399649.5 linkc.5127C>T p.Phe1709Phe synonymous_variant Exon 41 of 46 1 ENSP00000382557.1
CACNA1CENST00000399597.5 linkc.5109C>T p.Phe1703Phe synonymous_variant Exon 42 of 47 1 ENSP00000382506.1
CACNA1CENST00000399601.5 linkc.5109C>T p.Phe1703Phe synonymous_variant Exon 42 of 47 1 ENSP00000382510.1
CACNA1CENST00000399641.6 linkc.5109C>T p.Phe1703Phe synonymous_variant Exon 42 of 47 1 ENSP00000382549.1
CACNA1CENST00000399644.5 linkc.5109C>T p.Phe1703Phe synonymous_variant Exon 42 of 47 1 ENSP00000382552.1
CACNA1CENST00000682835.1 linkc.5109C>T p.Phe1703Phe synonymous_variant Exon 42 of 47 ENSP00000507282.1
CACNA1CENST00000683482.1 linkc.5100C>T p.Phe1700Phe synonymous_variant Exon 42 of 47 ENSP00000507169.1
CACNA1CENST00000682686.1 linkc.5076C>T p.Phe1692Phe synonymous_variant Exon 41 of 46 ENSP00000507309.1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.00000959
AC:
2
AN:
208594
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000613
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000107
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000492
AC:
7
AN:
1423846
Hom.:
0
Cov.:
31
AF XY:
0.00000142
AC XY:
1
AN XY:
703652
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32724
American (AMR)
AF:
0.00
AC:
0
AN:
41698
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23982
East Asian (EAS)
AF:
0.0000259
AC:
1
AN:
38646
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79638
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51104
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5622
European-Non Finnish (NFE)
AF:
0.00000458
AC:
5
AN:
1091646
Other (OTH)
AF:
0.0000170
AC:
1
AN:
58786
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.411
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Long QT syndrome Benign:1
Jan 16, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Aug 19, 2021
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.38
CADD
Benign
7.8
DANN
Benign
0.87
PhyloP100
-0.092

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs767569416; hg19: chr12-2788627; API